Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Renflexis PI 24 Jul 2019
APO-Calcitriol CMI 24 Jul 2019
APO-Calcitriol PI 24 Jul 2019
Apo-Pravastatin PI 24 Jul 2019
Hydopa CMI 24 Jul 2019

New products

Product name Type Date released
Skyrizi PI 18 Jul 2019
Skyrizi CMI 18 Jul 2019
Ogivri CMI 15 Jul 2019
Ogivri PI 12 Jul 2019
APO-Chloramphenicol PI 08 Jul 2019